Institute of Pharmaceutical Innovation and China National Academy of Nanotechnology and Engineering to collaborate.
The Institute of Pharmaceutical Innovation is teaming up with the China National Academy of Nanotechnology and Engineering (CNANE), in a joint initiative focused on the development of novel therapeutic nanoparticles.
The IPI is a leading research facility with expertise in drug formulation and delivery technology and active research programs in the nanotechnology field. CNANE is a multidisciplinary non-for-profit organization co-founded by the Chinese Academy of Science, Peking University, and Tsinghua University.
